vs

Side-by-side financial comparison of DT Midstream, Inc. (DTM) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

DT Midstream, Inc. is the larger business by last-quarter revenue ($317.0M vs $208.9M, roughly 1.5× iRhythm Holdings, Inc.). DT Midstream, Inc. runs the higher net margin — 35.0% vs 2.7%, a 32.3% gap on every dollar of revenue. On growth, DT Midstream, Inc. posted the faster year-over-year revenue change (27.3% vs 27.1%). DT Midstream, Inc. produced more free cash flow last quarter ($30.0M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 14.9%).

Oneok, Inc. ONE-oak, stylized as ONEOK, is an American oil and gas midstream operator headquartered in Tulsa, Oklahoma. It provides the oil and gas industry with gathering, processing, fractionation, transportation, and storage services. The company is part of the Fortune 500 and S&P 500. Oneok was founded as Oklahoma Natural Gas Company in 1906, but it changed its corporate name to Oneok in 1980.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

DTM vs IRTC — Head-to-Head

Bigger by revenue
DTM
DTM
1.5× larger
DTM
$317.0M
$208.9M
IRTC
Growing faster (revenue YoY)
DTM
DTM
+0.2% gap
DTM
27.3%
27.1%
IRTC
Higher net margin
DTM
DTM
32.3% more per $
DTM
35.0%
2.7%
IRTC
More free cash flow
DTM
DTM
$15.5M more FCF
DTM
$30.0M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
14.9%
DTM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DTM
DTM
IRTC
IRTC
Revenue
$317.0M
$208.9M
Net Profit
$111.0M
$5.6M
Gross Margin
70.9%
Operating Margin
49.2%
1.1%
Net Margin
35.0%
2.7%
Revenue YoY
27.3%
27.1%
Net Profit YoY
52.1%
518.5%
EPS (diluted)
$1.07
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTM
DTM
IRTC
IRTC
Q4 25
$317.0M
$208.9M
Q3 25
$314.0M
$192.9M
Q2 25
$309.0M
$186.7M
Q1 25
$303.0M
$158.7M
Q4 24
$249.0M
$164.3M
Q3 24
$248.0M
$147.5M
Q2 24
$244.0M
$148.0M
Q1 24
$240.0M
$131.9M
Net Profit
DTM
DTM
IRTC
IRTC
Q4 25
$111.0M
$5.6M
Q3 25
$115.0M
$-5.2M
Q2 25
$107.0M
$-14.2M
Q1 25
$108.0M
$-30.7M
Q4 24
$73.0M
$-1.3M
Q3 24
$88.0M
$-46.2M
Q2 24
$96.0M
$-20.1M
Q1 24
$97.0M
$-45.7M
Gross Margin
DTM
DTM
IRTC
IRTC
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
DTM
DTM
IRTC
IRTC
Q4 25
49.2%
1.1%
Q3 25
49.4%
-4.4%
Q2 25
50.2%
-10.0%
Q1 25
48.8%
-20.5%
Q4 24
45.4%
-2.5%
Q3 24
49.2%
-34.1%
Q2 24
53.3%
-15.5%
Q1 24
51.7%
-28.9%
Net Margin
DTM
DTM
IRTC
IRTC
Q4 25
35.0%
2.7%
Q3 25
36.6%
-2.7%
Q2 25
34.6%
-7.6%
Q1 25
35.6%
-19.3%
Q4 24
29.3%
-0.8%
Q3 24
35.5%
-31.3%
Q2 24
39.3%
-13.6%
Q1 24
40.4%
-34.6%
EPS (diluted)
DTM
DTM
IRTC
IRTC
Q4 25
$1.07
$0.18
Q3 25
$1.13
$-0.16
Q2 25
$1.04
$-0.44
Q1 25
$1.06
$-0.97
Q4 24
$0.73
$-0.03
Q3 24
$0.90
$-1.48
Q2 24
$0.98
$-0.65
Q1 24
$0.99
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTM
DTM
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$54.0M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.7B
$152.7M
Total Assets
$10.1B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTM
DTM
IRTC
IRTC
Q4 25
$54.0M
$583.8M
Q3 25
$98.0M
$565.2M
Q2 25
$74.0M
$545.5M
Q1 25
$83.0M
$520.6M
Q4 24
$68.0M
$535.6M
Q3 24
$77.0M
$522.0M
Q2 24
$73.0M
$561.5M
Q1 24
$41.0M
$569.1M
Total Debt
DTM
DTM
IRTC
IRTC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$3.4B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DTM
DTM
IRTC
IRTC
Q4 25
$4.7B
$152.7M
Q3 25
$4.7B
$121.9M
Q2 25
$4.7B
$103.7M
Q1 25
$4.6B
$86.7M
Q4 24
$4.6B
$90.9M
Q3 24
$4.2B
$71.8M
Q2 24
$4.2B
$99.2M
Q1 24
$4.2B
$90.3M
Total Assets
DTM
DTM
IRTC
IRTC
Q4 25
$10.1B
$1.0B
Q3 25
$10.1B
$995.2M
Q2 25
$10.0B
$964.0M
Q1 25
$9.9B
$926.1M
Q4 24
$9.9B
$931.4M
Q3 24
$8.6B
$909.7M
Q2 24
$9.0B
$919.2M
Q1 24
$9.0B
$909.8M
Debt / Equity
DTM
DTM
IRTC
IRTC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.72×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTM
DTM
IRTC
IRTC
Operating Cash FlowLast quarter
$161.0M
$26.2M
Free Cash FlowOCF − Capex
$30.0M
$14.5M
FCF MarginFCF / Revenue
9.5%
6.9%
Capex IntensityCapex / Revenue
41.3%
5.6%
Cash ConversionOCF / Net Profit
1.45×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$441.0M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTM
DTM
IRTC
IRTC
Q4 25
$161.0M
$26.2M
Q3 25
$274.0M
$34.9M
Q2 25
$185.0M
$27.7M
Q1 25
$247.0M
$-7.9M
Q4 24
$152.0M
$19.2M
Q3 24
$205.0M
$24.3M
Q2 24
$165.0M
$11.8M
Q1 24
$241.0M
$-52.0M
Free Cash Flow
DTM
DTM
IRTC
IRTC
Q4 25
$30.0M
$14.5M
Q3 25
$131.0M
$20.1M
Q2 25
$104.0M
$17.3M
Q1 25
$176.0M
$-17.3M
Q4 24
$62.0M
$12.4M
Q3 24
$124.0M
$15.5M
Q2 24
$84.0M
$3.4M
Q1 24
$143.0M
$-61.8M
FCF Margin
DTM
DTM
IRTC
IRTC
Q4 25
9.5%
6.9%
Q3 25
41.7%
10.4%
Q2 25
33.7%
9.3%
Q1 25
58.1%
-10.9%
Q4 24
24.9%
7.5%
Q3 24
50.0%
10.5%
Q2 24
34.4%
2.3%
Q1 24
59.6%
-46.8%
Capex Intensity
DTM
DTM
IRTC
IRTC
Q4 25
41.3%
5.6%
Q3 25
45.5%
7.7%
Q2 25
26.2%
5.6%
Q1 25
23.4%
5.9%
Q4 24
36.1%
4.2%
Q3 24
32.7%
6.0%
Q2 24
33.2%
5.7%
Q1 24
40.8%
7.4%
Cash Conversion
DTM
DTM
IRTC
IRTC
Q4 25
1.45×
4.70×
Q3 25
2.38×
Q2 25
1.73×
Q1 25
2.29×
Q4 24
2.08×
Q3 24
2.33×
Q2 24
1.72×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTM
DTM

Pipeline Segment$173.0M55%
Gathering Segment$144.0M45%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons